Gene · 5898
Papers2,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Räl-manapanmirr ga dhä-manapanmirr - Collaborating and connecting: Creating an educational process and multimedia resources to facilitate intercultural communication. | Int J Speech Lang Pathol | 2022 | 35633090 | PubTator, text mining | PubMed |
| Current Knowledge on Exosome Biogenesis, Cargo-Sorting Mechanism and Therapeutic Implications. | Membranes (Basel) | 2022 | 35629824 | PubTator, text mining | PubMed |
| Protein Prenyltransferases and Their Inhibitors: Structural and Functional Characterization. | Int J Mol Sci | 2022 | 35628237 | PubTator, text mining | PubMed |
| The RAL Enigma: Distinct Roles of RALA and RALB in Cancer. | Cells | 2022 | 35626682 | PubTator, text mining | PubMed |
| Platelet, Fibrinolytic and Other Coagulation Abnormalities in Newly-Diagnosed Patients with Chronic Thromboembolic Pulmonary Hypertension. | Diagnostics (Basel) | 2022 | 35626393 | PubTator, text mining | PubMed |
| Computational analysis of missense filamin-A variants, including the novel p.Arg484Gln variant of two brothers with periventricular nodular heterotopia. | PLoS One | 2022 | 35613087 | PubTator, text mining | PubMed |
| Identifying Barriers to Enrollment in Patient Pregnancy Registries: Building Evidence Through Crowdsourcing. | JMIR Form Res | 2022 | 35612888 | PubTator, text mining | PubMed |
| A mechanism for exocyst-mediated tethering via Arf6 and PIP5K1C-driven phosphoinositide conversion. | Curr Biol | 2022 | 35609603 | PubTator, text mining | PubMed |
| Mitochondrial transfer/transplantation: an emerging therapeutic approach for multiple diseases. | Cell Biosci | 2022 | 35590379 | PubTator, text mining | PubMed |
| Confirmed disability progression as a marker of permanent disability in multiple sclerosis. | Eur J Neurol | 2022 | 35582938 | PubTator, text mining | PubMed |
| Stereospecific lasofoxifene derivatives reveal the interplay between estrogen receptor alpha stability and antagonistic activity in ESR1 mutant breast cancer cells. | Elife | 2022 | 35575456 | PubTator, text mining | PubMed |
| In situ expression of ERG protein in the context of tumor heterogeneity identifies prostate cancer patients with inferior prognosis. | Mol Oncol | 2022 | 35574900 | PubTator, text mining | PubMed |
| β-Arrestin2 Is Critically Involved in the Differential Regulation of Phosphosignaling Pathways by Thyrotropin-Releasing Hormone and Taltirelin. | Cells | 2022 | 35563779 | PubTator, text mining | PubMed |
| Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker. | Cells | 2022 | 35563721 | PubTator, text mining | PubMed |
| CfDNA Measurement as a Diagnostic Tool for the Detection of Brain Somatic Mutations in Refractory Epilepsy. | Int J Mol Sci | 2022 | 35563270 | PubTator, text mining | PubMed |
| Evaluating a Panel of Autoantibodies Against Tumor-Associated Antigens in Human Osteosarcoma. | Front Genet | 2022 | 35547257 | PubTator, text mining | PubMed |
| A Molecular Hepatocellular Carcinoma Prognostic Score System Precisely Predicts Overall Survival of Hepatocellular Carcinoma Patients. | J Clin Transl Hepatol | 2022 | 35528976 | PubTator, text mining | PubMed |
| Genetic and Clinical Features of Heterotaxy in a Prenatal Cohort. | Front Genet | 2022 | 35518361 | PubTator, text mining | PubMed |
| Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives. | Front Pharmacol | 2022 | 35517800 | PubTator, text mining | PubMed |
| Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View. | Front Cell Dev Biol | 2022 | 35493073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5898/papers?page=20